(2005). BH: Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer.
(2008). ButtnerEnnever JA: Perioculomotor cell groups in monkey and man defined by their histochemical and functional properties: reappraisal of the Edinger-Westphal nucleus.
(2004). CC: YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate
(2006). Expression and polysome association of YB-1 in various tissues at different stages in the lifespan of mice. Biochim Biophys Acta
(2007). Gene expression profile in temporal lobe epilepsy. Neuroscientist
(1999). H: Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer
(2001). HD: Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.
(1992). HD: Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42 kD nuclear CCAAT binding protein. Nucleic Acids Res
(2002). HD: Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.
(2005). Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Clin Cancer Res
(2003). Isolation and characterization of brain Y-box protein: developmentally regulated expression, polyribosomal association and dendritic localization. Brain Res Mol Brain Res
(1998). Iwamoto Y: Nuclear expression of YB1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res
(2003). Kohno K: The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesisrelated factors in human malignancies. Cancer Sci
(2003). Kuwano M: The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays
(2006). NE: Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neurosci Lett
(2003). Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
(1997). Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med
(2004). Okano H: Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1. Neurosci Lett
(2004). Ovchinnikov LP: Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res
(2006). PH: Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle
(2006). Pitkanen A: Epileptogenesisrelated genes revisited. Prog Brain Res
(2005). Potschka H: Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci
(2008). Potschka H: Effect of aging on neurogenesis in the canine brain. Aging Cell
(2008). Potschka H: Seizure-induced up-regulation of P-glycoprotein at the bloodbrain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol
(2007). Stavrovskaya AA: Development of drug resistance in the population of colon cancer cells under the effect of multifunctional protein YB-1. Bull Exp Biol Med
(1995). The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
(2007). Tsuneyoshi M: Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci
(2006). W: A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol Aging
(2007). What makes tumors multidrug resistant? Cell Cycle